Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Entasis Therapeutics Holdings Inc (ETTX)

Entasis Therapeutics Holdings Inc (ETTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Entasis Therapeutics Holdings Inc 35 GATEHOUSE DRIVE WALTHAM MA 02451 USA

www.entasistx.com P: 781-810-0120

Description:

Entasis Therapeutics Holdings Inc. produces, researches and develops antibacterial therapies and drugs through its subsidiaries. The company's product pipeline consists of etx2514sul, zoliflodacin, etx0282cpdp and nbp program which are in clinical stage. Entasis Therapeutics Holdings, Inc. is based in Waltham, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 104,796
Enterprise Value, $K 104,796
Shares Outstanding, K 47,852
Annual Sales, $ 0 K
Annual Net Income, $ -47,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -15,262 K
60-Month Beta 1.33
% of Insider Shareholders 6.50%
% of Institutional Shareholders 6.91%
Float, K 44,742
% Float 93.50%
Short Volume Ratio 0.52

Growth:

1-Year Return -11.16%
3-Year Return -65.35%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 04/27/22
Latest Earnings Date 08/10/22
Earnings Per Share ttm -0.83
EPS Growth vs. Prev Qtr -28.00%
EPS Growth vs. Prev Year -10.34%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ETTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -145.48%
Return-on-Assets % -103.75%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.30
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar